+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

Antibody Market 2025-2029 - Product Thumbnail Image

Antibody Market 2025-2029

  • Report
  • July 2025
  • 246 Pages
  • Global
From
Heart Transplantation Therapeutics Market 2025-2029 - Product Thumbnail Image

Heart Transplantation Therapeutics Market 2025-2029

  • Report
  • February 2025
  • 252 Pages
  • Global
From
Bispecific Antibodies for Cancer Market 2025-2029 - Product Thumbnail Image

Bispecific Antibodies for Cancer Market 2025-2029

  • Report
  • February 2025
  • 233 Pages
  • Global
From
Janus Kinase (JAK) Inhibitors Market 2024-2028 - Product Thumbnail Image

Janus Kinase (JAK) Inhibitors Market 2024-2028

  • Report
  • October 2024
  • 145 Pages
  • Global
From
Human Immunoglobulin Market 2024-2028 - Product Thumbnail Image

Human Immunoglobulin Market 2024-2028

  • Report
  • August 2024
  • 215 Pages
  • Global
From
Uveitis Drugs Market 2024-2028 - Product Thumbnail Image

Uveitis Drugs Market 2024-2028

  • Report
  • August 2024
  • 143 Pages
  • Global
From
Myasthenia Gravis: Opportunity Assessment and Forecast - Product Thumbnail Image

Myasthenia Gravis: Opportunity Assessment and Forecast

  • Report
  • June 2025
  • 85 Pages
  • Global
From
From
From
From
Alopecia Areata: Opportunity Assessment and Forecast to 2033 - Product Thumbnail Image

Alopecia Areata: Opportunity Assessment and Forecast to 2033

  • Report
  • March 2025
  • 81 Pages
  • Global
From
From
Febrile Neutropenia - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Febrile Neutropenia - Global Clinical Trials Review, 2024

  • Clinical Trials
  • December 2024
  • 201 Pages
  • Global
From
Opioid Addiction: Opportunity Assessment and Forecast - Product Thumbnail Image

Opioid Addiction: Opportunity Assessment and Forecast

  • Report
  • October 2024
  • 80 Pages
  • Global
From
From
Celiac Disease: Competitive Landscape - Product Thumbnail Image

Celiac Disease: Competitive Landscape

  • Report
  • August 2024
  • 63 Pages
  • Global
From
Systemic Scleroderma Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Systemic Scleroderma Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Wiskott-Aldrich Syndrome Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Wiskott-Aldrich Syndrome Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Vitiligo Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Vitiligo Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more